NASDAQ
INGN
Last Price
US $6.33
KEY FIGURES
MKT CAP
$171.4M
EPS
TTM
$-0.91
PEG
TTM
-
P/E
TTM
N/M
P/S
TTM
0.49x
YIELD
0.00%
GROWTH
Revenue Y/Y
2.48%
(FY vs FY)
EBITDA Y/Y
Cash Flow (DCF)
Fair Value
Market $6.33
—
Default assumptions
EBITDA Multiple
Fair Value
Market $6.33
-60.98%
Default assumptions
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Inogen, Inc. cash flow to debt ratio of -64.18% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial risk - Healthy cash flow growth.
Inogen, Inc.'s free cash flow has decreased 93.21% from $-11.18M last year to $-21.60M, signaling decreasing performance
Financial stability - Healthy debt to equity ratio.
Inogen, Inc.'s debt to equity ratio is 0.09, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.
Financial stability - Healthy debt to equity ratio development.
Inogen, Inc.'s debt has decreased relative to shareholder equity from 0.11 last year to 0.09 today, signaling strengthened financials
Financial risk - Net debt/EBITDA.
Inogen, Inc. has negative EBITDA, making leverage ratio unreliable
Financial stability - ICR.
Inogen, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.
Financial stability - Profit margin growth.
Inogen, Inc.'s profit margin has increased (-33.74%) in the last year from -10.69% to -7.08%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Inogen, Inc.'s short-term assets of $198.30M exceed its short-term liabilities of $63.53M
Decreasing performance - ROA.
Inogen, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Inogen, Inc.'s return on equity of -12.90%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Inogen, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
Inogen, Inc. had positive net income in only 0.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
Inogen, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Inogen, Inc. has negative free cash flow, indicating cash burn
Increasing performance - Healthy earnings growth.
Inogen, Inc.'s yearly earnings has increased -36.62% since last year from $-35.89M to $-22.75M, signaling increasing performance
Increasing performance - Healthy revenue growth.
Inogen, Inc.'s yearly revenue has increased 3.86% since last year from $335.70M to $348.67M, signaling increasing performance
Decreasing performance - ROIC.
ROIC -13.21% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Decreasing performance - 3-year revenue CAGR.
Inogen, Inc.'s 3-year revenue CAGR of -2.59% is negative, indicating declining revenue over the past 3 years
Increasing performance - Revenue consistency.
Inogen, Inc. had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
Inogen, Inc. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
Inogen, Inc. has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Inogen, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Inogen, Inc. is overvalued relative to its fair value price of 2.47 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Inogen, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Inogen, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
Inogen, Inc. has a price-to-book ratio of 0.95x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Inogen, Inc. has a price-to-sales ratio of 0.49x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-12.90%
Return on equity
ROIC: -13.21%
Valuation History
-7.2X
Price to Earnings
EV/EBITDA: -19.0X
Cash flow
Profit margin
-
(FY vs FY)
Cash flow Y/Y
-
(FY vs FY)
EARNINGS FV (GRAHAM)
Fair Value
Market $6.33
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.